创伤引起的凝血病的治疗方法:系统审查和元分析议定书
Yuki Itagaki1, Mineji Hayakawa1,2, Yuki Takahashi1
1Department of Emergency Medicine, Hokkaido Univerisity, Sapporo, Japan.
JMIR research protocols
|December 11, 2023
概括
本系统性审查评估了创伤诱导凝血病 (TIC) 的干预措施,这是严重受伤导致的出血障碍. 它综合了治疗方法的证据,比如胺酸和血液制品,以改善患者的治疗结果.
科学领域:
- 创伤和紧急医疗医学
- 血液学和凝血障碍 血液学和凝血障碍
- 证据综合和元分析
背景情况:
- 创伤诱发性凝血病 (TIC) 是一种严重的疾病,在严重受伤后表现为异常的血液凝结和出血.
- 目前用于TIC的治疗方法缺乏关于其有效性和安全性的明确证据.
- 需要对ICT管理现有研究进行全面综合.
研究的目的:
- 系统地审查和分析治疗创伤诱导凝血病 (TIC) 的干预措施的有效性和安全性.
- 评价包括凝血因子缩剂,胺酸和血液成分制品在内的治疗方法.
主要方法:
- 随机和非随机对照试验的系统综述和元分析,以及对TIC严重创伤患者的观察性研究.
- 搜索了MEDLINE (PubMed),科学网和科克伦控制试验中央注册表.
- 使用Cochrane工具评估偏差风险,使用GRADE评估证据的强度.
主要成果:
- 使用PRISMA流程图总结研究选择.
- 以表格和图表呈现的证据,包括用于元分析结果的森林地块.
- 主要结局是住院死亡率.
结论:
- 这一审查将提供有关TIC关键干预措施的有效性和安全性的最新证据.
- 它旨在成为第一个专门关注ICT管理的系统审查和元分析.
- 这些发现将为治疗创伤诱导的凝血病的临床实践提供信息.
相关概念视频
Extrinsic and Intrinsic Pathways of Hemostasis
7.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.9K
Introduction to Hemostasis
8.0K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.0K
Coagulation
6.8K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.8K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
708
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
708


